Literature DB >> 8300210

Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.

K F Tai1, Y Ma, J J Weis.   

Abstract

Borrelia burgdorferi produces potent cell-activating molecules capable of stimulating polyclonal proliferation and immunoglobulin production by murine B lymphocytes and cytokine production by a variety of cell types. These stimulatory molecules function in infected mice, resulting in elevated levels of circulating immunoglobulins and serum interleukin-6. We have recently demonstrated that the purified outer surface lipoproteins OspA and OspB possess these properties. To assess their possible involvement in human disease, we determined whether cells from normal human donors could respond to these activities. Normal human B lymphocytes but not T lymphocytes proliferated when incubated with either sonicated B. burgdorferi or purified OspA. Sonicated B. burgdorferi was efficient at stimulating immunoglobulin M production by human mononuclear cell cultures; however, purified OspA was relatively inactive. Both sonicated B. burgdorferi and purified OspA stimulated production of high levels of interleukin-6 by mononuclear cells. These findings extend our observations with the mouse model and suggest that the stimulatory lipoproteins could indeed be involved in the symptoms and pathologies of human infection with B. burgdorferi.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8300210      PMCID: PMC186137          DOI: 10.1128/iai.62.2.520-528.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Lyme disease, 1988: immunologic manifestations and possible immunopathogenetic mechanisms.

Authors:  L H Sigal
Journal:  Semin Arthritis Rheum       Date:  1989-02       Impact factor: 5.532

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  IL-6 is the principal factor produced by synovia of patients with rheumatoid arthritis that induces B-lymphocytes to secrete immunoglobulins.

Authors:  Y Nawata; E M Eugui; S W Lee; A C Allison
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody.

Authors:  A G Barbour; S L Tessier; W J Todd
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

6.  Lyme disease-a tick-borne spirochetosis?

Authors:  W Burgdorfer; A G Barbour; S F Hayes; J L Benach; E Grunwaldt; J P Davis
Journal:  Science       Date:  1982-06-18       Impact factor: 47.728

7.  In vivo and in vitro evidence of B cell hyperactivity during Lyme disease.

Authors:  L H Sigal; A C Steere; J M Dwyer
Journal:  J Rheumatol       Date:  1988-04       Impact factor: 4.666

Review 8.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

9.  Clonal polymorphisms of outer membrane protein OspB of Borrelia burgdorferi.

Authors:  V G Bundoc; A G Barbour
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

10.  Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody.

Authors:  T F Tedder; L T Clement; M D Cooper
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

View more
  32 in total

1.  Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi.

Authors:  C L Croke; E L Munson; S D Lovrich; J A Christopherson; M C Remington; D M England; S M Callister; R F Schell
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen.

Authors:  S T Sadiq; J McSorley; A J Copas; J Bennett; S J Edwards; S Kaye; S Kirk; P French; I V D Weller
Journal:  Sex Transm Infect       Date:  2005-10       Impact factor: 3.519

3.  Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14.

Authors:  G H Giambartolomei; V A Dennis; B L Lasater; M T Philipp
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.

Authors:  J Ma; C Gingrich-Baker; P M Franchi; P Bulger; R T Coughlin
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

Review 5.  Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

Authors:  B Henderson; S Poole; M Wilson
Journal:  Microbiol Rev       Date:  1996-06

6.  Surface exposure and species specificity of an immunoreactive domain of a 66-kilodalton outer membrane protein (P66) of the Borrelia spp. that cause Lyme disease.

Authors:  J Bunikis; L Noppa; Y Ostberg; A G Barbour; S Bergström
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

7.  Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients.

Authors:  I Diterich; L Härter; D Hassler; A Wendel; T Hartung
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

8.  Lyme borreliosis in rhesus macaques: effects of corticosteroids on spirochetal load and isotype switching of anti-borrelia burgdorferi antibody.

Authors:  A R Pachner; K Amemiya; M Bartlett; H Schaefer; K Reddy; W F Zhang
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

9.  Borrelia burgdorferi vesicle production occurs via a mechanism independent of immunoglobulin M involvement.

Authors:  R J Shoberg; D D Thomas
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.

Authors:  K P Seiler; Z Vavrin; E Eichwald; J B Hibbs; J J Weis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.